Transdermal drug delivery enhancement by compounds of natural origin

Molecules

Volumn 16, Issue 12, 2011, Pages 10507-10540

  Fox, Lizelle T ^a   Gerber, Minja ^a   Du Plessis, Jeanetta ^a   Hamman, Josias H ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

Author keywords

Essential oil; Natural; Penetration enhancer; Polysaccharide; Terpene

Indexed keywords

EID: 84555189783     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules161210507     Document Type: Review

References (91)

1. Mezei, M. Liposomes as penetration promoters and localizers of topically applied drugs. In Drug Permeation Enhancement: Theory and Applications, Hsieh, D.S., Ed.; Marcel Dekker: New York, NY, USA, 1994; pp. 171-198.
2. Ghafourian, T.; Samaras, E.G.; Brooks, J.D.; Riviere, J.E. Validated models for predicting skin penetration from different vehicles. Eur. J. Pharm. Sci. 2010, 41, 612-616.
3. Fang, J.-Y.; Leu, Y.-L.; Hwang, T.-L.; Chen, H.-C.; Hung, C.-F. Development of sesquiterpenes from alpinia oxyphylla as novel skin permeation enhancers. Eur. J. Pharm. Sci. 2003, 19, 253-262. (Pubitemid 36918418)
4. Shah, V.P. Skin penetration enhancers: Scientific perspectives. In Drug Permeation Enhancement: Theory and Applications, Hsieh, D.S., Ed.; Marcel Dekker: New York, NY, USA, 1994; pp. 19-23.
5. Cornwell, P.A.; Barry, B.W.; Bouwstra, J.A.; Gooris, G.S. Modes of action of terpene penetration enhancers in human skin; Differential scanning calorimetry, small-angle X-ray diffraction and enhancer uptake studies. Int. J. Pharm. 1996, 127, 9-26. (Pubitemid 26069150)
6. Hadgraft, J. Skin deep. Eur. J. Pharm. Biopharm. 2004, 58, 291-299. (Pubitemid 39037236)
7. Hadgraft, J. Skin, the final frontier. Int. J. Pharm. 2001, 224, 1-18.
8. Hsieh, D.S. Understanding permeation enhancement technologies. In Drug Permeation Enhancement: Theory and Applications, Hsieh, D.S., Ed.; Marcel Dekker: New York, NY, USA, 1994; pp. 3-17.
9. Law, S.; Wertz, P.W.; Swartzendruber, D.C.; Squier, C.A. Regional variation in content, composition and organisation of porcine epithelial barrier lipids revealed by thin-layer chromatography and transmission electron microscopy. Arch. Oral Biol. 1995, 40, 1085-1091.
10. Chen, H.-C.; Mendelsohn, R.; Rerek, M.E.; Moore, D.J. Fourier transform infrared spectroscopy and differential scanning calorimetry studies of fatty acid homogeneous ceramide 2. Biochim. Biophys. Acta 2000, 1468, 293-303.
11. Moore, D.J.; Rerek, M.E. Insights into the molecular organisation of lipids in the skin barrier from infrared spectroscopy studies of stratum corneum lipid models. Acta Derm. Venereol. 2000, 298, 16-22.
12. Ho, C.K. Probabilistic modeling of percutaneous absorption for risk-based exposure assessments and transdermal drug delivery. Stat. Methodol. 2004, 1, 47-69. (Pubitemid 43339374)
13. Roy, S.D. Preformulation aspects of transdermal drug delivery systems. In Transdermal and Topical Drug Delivery Systems, Ghosh, T.K., Pfister, W.R., Yum, S.I., Eds.; Interpharm Press: Buffalo Grove, IL, USA, 1997; pp. 139-166.
14. Naik, A.; Kalia, Y.N.; Guy, R.H. Transdermal drug delivery: Overcoming the skin's barrier function. Pharm. Sci. Tech. Today 2000, 3, 318-325.
15. Behl, C.R.; Char, H.; Patel, S.B.; Mehta, D.B.; Piemontese, D.; Malick, A.W. In vivo and in vitro skin uptake and permeation studies: Critical considerations and factors which affect them. In Topical Drug Bioavailability, Bioequivalence, and Penetration, Shah, V.P., Maibach, H.I., Eds.; Plenum Press: New York, NY, USA, 1993; pp. 225-259.
16. Hadgraft, J.; Williams, D.G.; Allan, G. Azone®: Mechanisms of action and clinical effect. In Pharmaceutical Skin Penetration Enhancement, Walters, K.A., Hadgraft, J., Eds.; Marcel Dekker: New York, NY, USA, 1993; pp. 175-197.
17. Charoo, N.A.; Shamsher, A.A.A.; Kohli, K.; Pillai, K.; Rahman, K. Improvement in bioavailability of transdermally applied flurbiprofen using tulsi (ocinum sanctum) and turpentine oil. Colloid. Surface. B 2008, 65, 300-307.
18. Walker, R.B.; Smith, E.W. The role of percutaneous penetration enhancers. Adv. Drug Deliver. Rev. 1996, 18, 295-301. (Pubitemid 26063305)
19. Thomas, B.J.; Finnin, B.C. The transdermal revolution. Drug Discov. Today 2004, 9, 697-703. (Pubitemid 39070282)
20. Foldvari, M. Non-invasive administration of drugs through the skin: challenges in delivery system design. Pharm. Sci. Technol. Today 2000, 3, 417-425.
21. Barry, B.W. Lipid-protein-partitioning theory of skin penetration enhancement. J. Control. Release 1991, 15, 237-248.
22. Pinder, A.R. The Chemistry of the Terpenes; Wiley: New York, NY, USA, 1960; pp. 1-223.
23. Stewart, D. The Chemistry of Essential Oils Made Simple: God's Love Manifest in Molecules; Care Publications: Marble Hill, MO, USA, 2005; pp. 55-591.
24. Essential Science Publishing. Essential Oils: Desk Reference, 3rd ed.; Essential Science Publishing: Orem, UT, USA, 2006; pp. 1-75.
25. Betts, T.J. Chemical characterisation of the different types of volatile oil constituents by various solute retention ratios with the use of conventional and novel commercial gas chromatographic stationary phases. J. Chromatog. A 2001, 936, 33-46. (Pubitemid 33044619)
26. Dudareva, N.; Pichersky, E.; Gershenzon, J. Biochemistry of plant volatiles. Plant Physiol. 2004, 135, 1893-1902. (Pubitemid 39182771)
27. Monti, D.; Chetoni, P.; Burgalassi, S.; Najarro, M.; Fabrizio Saettone, M.; Boldrini, E. Effect of different terpene-containing essential oils on permeation of estradiol through hairless mouse skin. Int. J. Pharm. 2002, 237, 209-214. (Pubitemid 34310493)
28. Monti, D.; Tampucci, S.; Chetoni, S.; Burgalassi, S.; Bertoli, A.; Pistelli, L. Niaouli oils from different sources: Analysis and influence on cutaneous permeation of estradiol in vitro. Drug Deliv. 2009, 16, 237-242.
29. Williams, A.C.; Barry, B.W. Essential oils as novel human skin penetration enhancers. Int. J. Pharm. 1989, 57, R7-R9.
30. Williams, A.C.; Barry, B.W. Terpenes and the lipid-protein-partitioning theory of skin penetration enhancement. Pharmaceut. Res. 1991, 8, 17-24.
31. Karpanen, T.J.; Conway, B.R.; Worthington, T.; Hilton, A.C.; Elliott, T.S.J.; Lambert, P.A. Enhanced chlorhexidine skin penetration with eucalyptus oil. BMC Infect. Dis. 2010, 10, 278.
32. Lee, E.; Park, K.-K.; Lee, J.-M.; Chun, K.-S.; Kang, J.-Y.; Lee, S.-S.; Surh, Y.-J. Suppression of mouse tumor promotion and induction of apoptosis in HL-60 cells by Alpinia oxyphylla Miquel (Zingiberaceae). Carcinogenesis 1998, 19, 1377-1381. (Pubitemid 28409834)
33. Fang, J.-Y.; Leu, Y.-L.; Hwang, T.-L.; Cheng, H.-C. Essential oils from sweet basil (ocimum basilicum) as novel enhancers to accelerate transdermal drug delivery. Biol. Pharm. Bull. 2004, 27, 1819-1825. (Pubitemid 41701611)
34. Jain, R.; Aqil, M.; Ahad, A.; Ali, A.; Khar, R.K. Basil oil is a promising skin penetration enhancer for transdermal delivery of labetolol hydrochloride. Drug Dev. Ind. Pharm. 2008, 34, 384-389. (Pubitemid 351519668)
35. Yamahara, J.; Kashiwa, H.; Kishi, K.; Fujimura, H. Dermal penetration enhancement by crude drugs: In vitro skin permeation of prednisolone enhanced by active constituents in cardamom seed. Chem. Pharm. Bull. 1989, 37, 855-856. (Pubitemid 19106150)
36. Huang, Y.-B.; Wu, P.-C.; Ko, H.-M.; Tsai, Y.-H. Cardamom oil as a skin permeation enhancer for indomethacin, piroxicam and diclofenac. Int. J. Pharm. 1995, 126, 111-117. (Pubitemid 26018575)
37. Huang, Y.-B.; Wu, P.-C.; Ko, H.-M.; Tsai, Y.-H. Effect of pretreatment by cardamom oil on in vivo percutaneous absorption of piroxicam gel: Pharmacokinetic analysis in rabbits. Int. J. Pharm. 1996, 134, 183-191. (Pubitemid 26175000)
38. Nielsen, J.B. Natural oils affect the human skin integrity and percutaneous penetration of benzoic acid dose-dependently. Basic Clin. Pharmacol. Toxicol. 2006, 98, 575-581.
39. Das, M.K.; Bhattacharya, A.; Ghosal, S.K. Effect of different terpene-containing essential oils on percutaneous absorption of trazodone hydrochloride through mouse epidermis. Drug Deliv. 2006, 13, 425-431. (Pubitemid 44470222)
40. Amin, S.; Kohli, K.; Khar, R.K.; Mir, S.R.; Pillai, K.K. Mechanism of in vitro percutaneous absorption enhancement of carvedilol by penetration enhancers. Pharm. Dev. Technol. 2008, 13, 533-539.
41. Thakur, R.A.; Wang, Y.; Michniak, B.B. Essential oils and terpenes. In Percutaneous Penetration Enhancers, 2nd ed.; Smith, E.W., Maibach, H.I., Eds.; CRC Press: Boca Raton, FL, USA, 2006; pp. 159-173.
42. Cornwell, P.A.; Barry, B.W. The routes of penetration of ions and 5-fluorouracil across human skin and the mechanisms of action of terpene skin penetration enhancers. Int. J. Pharm. 1993, 94, 189-194. (Pubitemid 23204065)
43. Gao, S.; Singh, J. In vitro percutaneous absorption enhancement of a lipophilic drug tamoxifen by terpenes. J. Control. Release 1998, 51, 193-199. (Pubitemid 28252871)
44. Torssell, K.B.G. Natural Product Chemistry: A Mechanistic and Biosynthetic Approach to Secondary Metabolism; Wiley: Chichester, UK, 1983; Chapter 5, pp. 167-225.
45. Cornwell, P.A.; Barry, B.W. Sesquiterpene components of volatile oils as skin penetration enhancers for the hydrophilic permeant 5-fluorouracil. J. Pharm. Pharmacol. 1994, 46, 261-269. (Pubitemid 24111129)
46. Lim, P.-F.-C.; Liu, X.-Y.; Kang, L.; Ho, P.-C.-L.; Chan, Y.-W.; Chan, S.-Y. Limonene GP1/PG organogel as a vehicle in transdermal delivery of haloperidol. Int. J. Pharm. 2006, 311, 157-164.
47. Clarys, P.; Alewaeters, K.; Jadoul, A.; Barel, A.; Manadas, R.U.; Préat, V. In vitro percutaneous penetration through hairless rat skin: Influence of temperature, vehicle and penetration enhancers. Eur. J. Pharm. Biopharm. 1998, 46, 279-283. (Pubitemid 29057674)
48. Femenía-Font, A.; Balaguer-Fernández, C.; Merino, V.; Rodilla, V.; López-Castellano, A. Effect of chemical enhancers on the in vitro percutaneous absorption of sumatriptan succinate. Eur. J. Pharm. Biopharm. 2005, 61, 50-55. (Pubitemid 41096688)
49. Moghimi, H.R.; Makhmalzadeh, B.S.; Manafi, A. Enhancement effect of terpenes on silver sulphadiazine permeation through third-degree burn eschar. Burns 2009, 35, 1165-1170.
50. Krishnaiah, Y.S.R.; Satyanarayana, V.; Bhaskar, P. Influence of limonene on the bioavailability of nicardipine hydrochloride from membrane-moderated transdermal therapeutic systems in human volunteers. Int. J. Pharm. 2002, 247, 91-102. (Pubitemid 35341141)
51. Jain, A.K.; Thomas, N.S.; Panchagnula, R. Transdermal drug delivery of imipramine hydrochloride.: I. Effect of terpenes. J. Control. Release 2002, 79, 93-101. (Pubitemid 34168193)
52. Kararli, T.T.; Kirchoff, C.F.; Penzotti, S.C., Jr. Enhancement of transdermal transport of azidothymidine (AZT) with novel terpene and terpene-like enhancers: In vivo-in vitro correlations. J. Control. Release 1995, 34, 43-51.
53. Amnuaikit, C.; Ikeuchi, I.; Ogawar, K.; Higaki, K.; Kimura, T. Skin permeation of propranolol from polymeric film containing terpene enhancers for transdermal use. Int. J. Pharm. 2005, 289, 167-178. (Pubitemid 40093551)
54. Krishnaiah, Y.S.R.; Satyanarayana, V.; Bhaskar, P. Formulation and in vivo evaluation of membrane-moderated transdermal therapeutic systems of nicardipine hydrochloride using carvone as a penetration enhancer. Drug Deliv. 2003, 10, 101-109. (Pubitemid 36588511)
55. Hanif, R.M.; Qineng, P.; Zhan, G. Penetration enhancing effect of tetrahydrogeraniol on the percutaneous absorption of 5-fluorouracil from gels in excised rat skin. J. Control. Release 1998, 55, 297-302. (Pubitemid 28477620)
56. Arellano, A.; Santoyo, S.; Martín, C.; Ygartua, P. Enhancing effect of terpenes on the in vitro percutaneous absorption of diclofenac sodium. Int. J. Pharm. 1996, 130, 141-145. (Pubitemid 26129793)
57. Godwin, D.A.; Michniak, B.B. Influence of drug lipophilicity on terpenes as transdermal penetration enhancers. Drug Dev. Ind. Pharm. 1999, 25, 905-915. (Pubitemid 29350272)
58. El-Kattan, A.F.; Asbill, C.S.; Kim, N.; Michniak, B.B. The effects of terpene enhancers on the percutaneous permeation of drugs with different lipophilicities. Int. J. Pharm. 2001, 215, 229-240. (Pubitemid 32206620)
59. Babu, R.J.; Singh, M.; Kanikkannan, N. Fatty alcohols and fatty acids. In Percutaneous Penetration Enhancers, 2nd ed.; Smith, E.W., Maibach, H.I., Eds.; CRC Press: Boca Raton, FL, USA, 2006; pp. 137-158.
60. Hjaltason, B. New frontiers in the processing and utilization of fish oil. In Nutritional Impact of Food Processing. Bibl. Nutr. Dieta., Somogyi, J.C., Müller, H.R., Eds.; Karger Publishing: Basel, Switzerland, 1989; pp. 96-106.
61. Loftsson, T.; Gu?mundsdóttir, T.K.; Fri?riksdótter, H.; Sugur?ardóttir, A.M.; Thorkelsson, J.; Gu?mundsson, G.; Hjaltason, B. Fatty acids from cod-liver oil as skin penetration enhancers. Pharmazie 1995, 50, 188-190.
62. Loftsson, T.; Thormar, H.; Ólafsson, J.H.; Gunnarsdóttir, T.M.; Hjaltsason, B.; Gudmundsson, G. Fatty acid extract from cod-liver oil: Activity against herpes simplex virus and enhancement of transdermal delivery of acyclovir in vitro. Pharm. Pharmacol. Commun. 1998, 4, 287-291. (Pubitemid 28297119)
63. Prescott, G.W. The Algae: A Review; Nelson: London, UK, 1969; Chapter 1, pp. 3-35.
64. Lee, R.E. Phycology, 3rd ed.; Cambridge University Press: Cambridge, UK, 1999; pp. 3-177.
65. Fang, J.-Y.; Chiu, H.-C.; Wu, J.-T.; Chiang, Y.-R.; Hsu, S.-H. Fatty acids in Botryococcus braunii accelerate topical delivery of flurbiprofen into and across skin. Int. J. Pharm. 2004, 276, 163-173. (Pubitemid 38542996)
66. Garrett, R.H.; Grisham, C.M. Principles of Biochemistry: With a Human Focus, 1st ed.; Brooks/Cole: Pacific Grove, CA, USA, 2001; pp. 158-633.
67. Yokomizo, Y.; Sagitani, H. Effects of phospholipids on the in vitro percutaneous penetration of prednisolone and analysis of mechanism by using attenuated total reflectance-fourier transform infrared spectroscopy. J. Pharm. Sci. 1996, 85, 1220-1226. (Pubitemid 26372892)
68. Valjakka-Koskela, R.; Kirjavainen, M.; Mönkkönen, J.; Urtti, A.; Kiesvaara, J. Enhancement of percutaneous absorption of naproxen by phospholipids. Int. J. Pharm. 1998, 175, 225-230. (Pubitemid 28517978)
69. Yokomizo, Y.; Sagitani, H. Effects of phospholipids on the percutaneous penetration of indomethacin through the dorsal skin of guinea pigs in vitro. J. Control. Release 1996, 38, 267-274. (Pubitemid 26098646)
70. Yokomizo, Y.; Sagitani, H. The effects of phospholipids on the percutaneous penetration of indomethacin through the dorsal skin of guinea pig in vitro. 2. The effects of the hydrophobic group in phospholipids and a comparison with general enhancers. J. Control. Release 1996, 42, 37-46. (Pubitemid 26297874)
71. Nashihata, T.; Kotera, K.; Nakano, Y.; Yamazaki, M. Rat percutaneous transport of diclofenac and influence of hydrogenated soya phospholipids. Chem. Pharm. Bull. 1987, 35, 3807-3812. (Pubitemid 18076873)
72. Kato, A.; Ishibashi, Y.; Miyake, Y. Effect of egg yolk lecithin on transdermal delivery of bunazosin hydrochloride. J. Pharm. Pharmacol. 1987, 39, 399-400. (Pubitemid 17119501)
73. Kimura, T.; Nagahara, N.; Hirabayashi, K.; Kurosaki, Y.; Nakayama, T. Enhanced percutaneous penetration of flufenamic acid using lipid disperse systems containing glycosylceramides. Chem. Pharm. Bull. 1989, 37, 454-457. (Pubitemid 19082589)
74. Kirjavainen, M.; Urtti, A.; Valjakka-Koskela, R.; Kiesvaara, J.; Mönkkönen, J. Liposome-skin interactions and their effects on the skin permeation of drugs. Eur. J. Pharm. Sci. 1999, 7, 279-286. (Pubitemid 29080739)
75. Mura, S.; Manconi, M.; Sinico, C.; Valenti, D.; Fadda, A.M. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil, J. Control. Release 2009, 380, 72-79.
76. Dragicevic-Curic, N.; Scheglmann, D.; Albrecht, V.; Fahr, A. Temoporfin-loaded invasomes: Development, characterization and in vitro skin penetration studies. J. Control. Release 2008, 127, 59-69.
77. Touitou, E.; Dayan, N.; Bergelson, L.; Godin, B.; Eliaz, M. Ethosomes-Novel vesicular carriers for enhanced delivery: Characterization and skin penetration properties. J. Control. Release 2000, 65, 403-418. (Pubitemid 30122942)
78. Burrows, F.; Louime, C.; Abazinge, M.; Onokpise, O. Extraction and evaluation of chitosan from crab exoskeleton as a seed fungicide and plant growth enhancer. Am. Eurasian J. Agric. Environ. Sci. 2007, 2, 103-111.
79. He, W.; Guo, X.; Xiao, L.; Feng, M. Study on the mechanisms of chitosan and its derivatives used as transdermal penetration enhancers. Int. J. Pharm. 2009, 382, 234-243.
80. He, W.; Guo, X.; Zhang, M. Transdermal permeation enhancement of N-trimethyl chitosan for testosterone. Int. J. Pharm. 2008, 356, 82-87.
81. Taveira, S.F.; Nomizo, A.; Lopez, R.F.V. Effect of the ionthophoresis of chitosan gel on doxorubicin skin penetration and cytotoxicity. J. Control. Release 2009, 134, 35-40.
82. Lv, H.-X.; Zhang, Z.-H.; Wang, X.-P.; Cheng, Q.-Q.; Wang, W.; Huang, X.-H.; Zhou, J.-P.; Zhang, Q.; Hou, L-L.; Huo, W. A biomimetic chitosan derivates: Preparation, characterisation and transdermal enhancement studies of N-Arginine chitosan. Molecules 2011, 16, 6778-6790.
83. Morton, J.F. Folk uses and commercial exploitation of Aloe leaf pulp. Econ. Bot. 1961, 15, 311-319.
84. Kim, Y.S. Carbohydrates. In New Perspectives on Aloe, Park, Y.I., Lee, S.K., Eds.; Springer Science: New York, NY, USA, 2006; pp. 57-62.
85. Loots, D.; Van der Westhuizen, F.H.; Botes, L. Aloe ferox leaf gel phytochemical content, antioxidant capacity and possible health benefits. J. Agric. Food Chem. 2007, 55, 6891-6896. (Pubitemid 47338923)
86. Cole, L.; Heard, C. Skin permeation enhancement potention of Aloe vera and a proposed mechanism of action based upon size exclusion and pull effect. Int. J. Pharm. 2007, 333, 10-16. (Pubitemid 46283265)
87. Ballam, L.; Heard, C.M. Pre-treatment with Aloe vera juice does not enhance the in vitro permeation of ketoprofen across skin. Skin Pharmacol. Physiol. 2010, 23, 113-116.
88. McGaw, D.R.; Holder, R.; Commissiong, E.; Maxwell, A. Extraction of Volatile and Fixed Oil Products from Hot Peppers. In Proceedings of the 6th International Symposium on Supercritical Fluids, International Society for Advancement of Supercritical Fluids, Versailles, France, 28-30 April 2003.
89. Fox, L.P.; Merk, H.F.; Bickers, D.R. Dermatological pharmacology. In Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 11th ed.; Brunton, L.L., Lazo, J.S., Parker, K.L., Eds.; McGraw-Hill: New York, NY, USA, 2006; pp. 1679-1706.
90. Degim, I.T.; Uslu, A.; Hadgraft, J.; Atay, T.; Akay, C.; Cevheroglu, S. The effects of Azone® and capsaicin on the permeation of naproxen through human skin. Int. J. Pharm. 1999, 179, 21-25. (Pubitemid 29115056)
91. Trivedi, J.S.; Krill, S.L.; Fort, J.J. Vitamin E as a human skin penetration enhancer. Eur. J. Pharm. Sci. 1995, 3, 241-243.